Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,784 | 24,252 | 20,429 | 38,323 | 53,681 |
| Marketable Securities | 323 | 444 | 441 | 888 | 656 |
| Receivables | 2,637 | 5,683 | 3,926 | 3,218 | 3,844 |
| TOTAL | $54,746 | $36,569 | $29,700 | $44,708 | $60,595 |
| Non-Current Assets | |||||
| PPE Net | 19,893 | 19,494 | 19,345 | 18,969 | 18,044 |
| Investments And Advances | 29,972 | 269,085 | 32,999 | 271,674 | 191,952 |
| Intangibles | 107,988 | 108,650 | 109,311 | 109,973 | 110,628 |
| Other Non-Current Assets | 239,922 | 3,081 | 240,258 | 3,440 | 3,549 |
| TOTAL | $397,775 | $400,310 | $401,913 | $404,056 | $324,173 |
| Total Assets | $452,521 | $436,879 | $431,613 | $448,764 | $384,768 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,511 | 1,594 | N/A | 2,407 | N/A |
| Accounts payable and accrued liabilities | 31,541 | 33,847 | 63,120 | 57,666 | 60,201 |
| Accrued Expenses | 4,226 | 13,336 | 11,759 | 8,599 | 9,402 |
| Other current liabilities | 243 | 251 | 212 | 13 | 14 |
| TOTAL | $39,399 | $51,524 | $78,955 | $83,351 | $79,283 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,203 | 5,501 | 5,211 | 24,575 | 26,541 |
| Deferred Revenues | 1,878 | 2,496 | 3,864 | 14,666 | 9,666 |
| Other Non-Current Liabilities | 6,871 | 6,948 | 6,261 | 2,243 | 5,605 |
| TOTAL | $153,657 | $144,482 | $146,048 | $263,124 | $209,289 |
| Total Liabilities | $193,056 | $196,006 | $225,003 | $346,475 | $288,572 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 116,732 | 92,825 | 87,434 | 79,322 | 76,540 |
| Common Shares | 12 | 10 | 9 | 9 | 9 |
| Retained earnings | -270,646 | -196,784 | -165,120 | -213,565 | -211,503 |
| Other shareholders' equity | 4,783 | 5,956 | 6,820 | 6,947 | 3,528 |
| TOTAL | $259,465 | $240,873 | $206,610 | $102,289 | $96,196 |
| Total Liabilities And Equity | $452,521 | $436,879 | $431,613 | $448,764 | $384,768 |